Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation
This Neumora Therapeutics Insider Increased Their Holding In The Last Year [Yahoo! Finance]
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression [Yahoo! Finance]
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]